Saverna Therapeutics AG Alternatives & Competitors
4 companies similar to Saverna Therapeutics AG — Saverna Therapeutics aims to discover highly active, selective and cell-permeabl...
Companies similar to Saverna Therapeutics AG
Envisagenics
Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures...
1910 Genetics
Advancing small and large molecule drug discovery with a multimodal AI platform powered by...
Lantern Pharma Inc. (Nasdaq: LTRN)
Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies
Iambic
Better technology for better medicines | Nasdaq: IAM
About Saverna Therapeutics AG
Saverna Therapeutics is a Swiss pharmaceutical start-up company founded in 2017 with the focus on developing small molecule drugs to target non-coding RNA for treating diseases with high unmet need. Founded by four former lab heads at Novartis, Switzerland, the company aims to leverage their expertise in a specialized...
Pharmaceutical Industry, Drug Discovery, Small Molecule Drugs, Non-coding RNA, Swiss Start-up, Disease Treatment, RNA-targeting Compounds, Inflammation, Cancer Research, Infection Treatment, Biomedical Research, Precision Medicine, Therapeutics Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Saverna Therapeutics AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Saverna Therapeutics AG on 11 Sep 2024. The 4 companies listed here were last checked between 2 Apr 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.